Literature DB >> 20160912

Interaction of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase complex.

Mulchand S Patel1, Lioubov G Korotchkina, Sukhdeep Sidhu.   

Abstract

The human (h) pyruvate dehydrogenase complex (hPDC) consists of multiple copies of several components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2), dihydrolipoamide dehydrogenase (E3), E3-binding protein (BP), and specific kinases and phosphatases. Mammalian PDC has a well organized structure with an icosahedral symmetry of the central E2/BP core to which the other component proteins bind non-covalently. Both hE2 and hBP consist of three well defined domains, namely the lipoyl domain, the subunit-binding domain and the inner domain, connected with flexible linkers. hE1 (alpha(2)beta(2)) binds to the subunit-binding domain of hE2; whereas hE3 binds to the E3-binding domain of hBP. Among several residues of the C-terminal surface of the hE1beta E1betaD289 was found to interact with hE2K276. The C-terminal residue I329 of the hE1beta did not participate in binding to hE2. This latter finding shows specificity in the interaction between E1beta and E2 in hPDC. The selective binding between hE3 and the E3-binding domain of hBP was investigated using specific mutants. E3R460G and E3340K showed significant reductions in affinity for hBP as determined by surface plasmon resonance. Both residues are involved in the structural organization of the binding site on hE3. Substitution of I157, N137 and R155 of hBP resulted in variable increases in the K(D) for binding with wild-type hE3, suggesting that the binding results from several weak electrostatic bonds and hydrophobic interactions among residues of hBP with residues at the interface of dimeric hE3. These results provide insight in the mono-specificity of binding of E1 to E2 and E3 to BP in hPDC and showed the differences in the binding of peripheral components (E1 and E3) in human and bacterial PDCs.

Entities:  

Year:  2009        PMID: 20160912      PMCID: PMC2770179          DOI: 10.1016/j.molcatb.2009.05.001

Source DB:  PubMed          Journal:  J Mol Catal B Enzym        ISSN: 1381-1177


  18 in total

1.  The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes.

Authors:  Z H Zhou; D B McCarthy; C M O'Connor; L J Reed; J K Stoops
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Structural basis for flip-flop action of thiamin pyrophosphate-dependent enzymes revealed by human pyruvate dehydrogenase.

Authors:  Ewa M Ciszak; Lioubov G Korotchkina; Paulina M Dominiak; Sukhdeep Sidhu; Mulchand S Patel
Journal:  J Biol Chem       Date:  2003-03-21       Impact factor: 5.157

3.  Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex.

Authors:  Chad A Brautigam; R Max Wynn; Jacinta L Chuang; Mischa Machius; Diana R Tomchick; David T Chuang
Journal:  Structure       Date:  2006-01-26       Impact factor: 5.006

4.  Characterization of testis-specific isoenzyme of human pyruvate dehydrogenase.

Authors:  Lioubov G Korotchkina; Sukhdeep Sidhu; Mulchand S Patel
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

5.  Lipoic acid as an antioxidant. The role of dihydrolipoamide dehydrogenase.

Authors:  M S Patel; Y S Hong
Journal:  Methods Mol Biol       Date:  1998

6.  The molecular origins of specificity in the assembly of a multienzyme complex.

Authors:  René A W Frank; J Venkatesh Pratap; Xue Y Pei; Richard N Perham; Ben F Luisi
Journal:  Structure       Date:  2005-08       Impact factor: 5.006

7.  Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency.

Authors:  Y S Hong; D S Kerr; W J Craigen; J Tan; Y Pan; M Lusk; M S Patel
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

8.  How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex.

Authors:  Ewa M Ciszak; Anna Makal; Young S Hong; Ananthalakshmy K Vettaikkorumakankauv; Lioubov G Korotchkina; Mulchand S Patel
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

9.  Amino-terminal residues 1-45 of the Escherichia coli pyruvate dehydrogenase complex E1 subunit interact with the E2 subunit and are required for activity of the complex but not for reductive acetylation of the E2 subunit.

Authors:  Yun-Hee Park; Wen Wei; Leon Zhou; Natalia Nemeria; Frank Jordan
Journal:  Biochemistry       Date:  2004-11-09       Impact factor: 3.162

10.  Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and Glu-457----Gln).

Authors:  H Kim; M S Patel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

View more
  14 in total

Review 1.  Spatial Organization of Metabolic Enzyme Complexes in Cells.

Authors:  Danielle L Schmitt; Songon An
Journal:  Biochemistry       Date:  2017-06-16       Impact factor: 3.162

2.  Insight to the interaction of the dihydrolipoamide acetyltransferase (E2) core with the peripheral components in the Escherichia coli pyruvate dehydrogenase complex via multifaceted structural approaches.

Authors:  Krishnamoorthy Chandrasekhar; Junjie Wang; Palaniappa Arjunan; Martin Sax; Yun-Hee Park; Natalia S Nemeria; Sowmini Kumaran; Jaeyoung Song; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

Review 3.  The pyruvate dehydrogenase complexes: structure-based function and regulation.

Authors:  Mulchand S Patel; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

4.  Characterization of interactions of dihydrolipoamide dehydrogenase with its binding protein in the human pyruvate dehydrogenase complex.

Authors:  Yun-Hee Park; Mulchand S Patel
Journal:  Biochem Biophys Res Commun       Date:  2010-04-10       Impact factor: 3.575

5.  Underlying molecular alterations in human dihydrolipoamide dehydrogenase deficiency revealed by structural analyses of disease-causing enzyme variants.

Authors:  Eszter Szabo; Piotr Wilk; Balint Nagy; Zsofia Zambo; David Bui; Andrzej Weichsel; Palaniappa Arjunan; Beata Torocsik; Agnes Hubert; William Furey; William R Montfort; Frank Jordan; Manfred S Weiss; Vera Adam-Vizi; Attila Ambrus
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

6.  Simulations of Pathogenic E1α Variants: Allostery and Impact on Pyruvate Dehydrogenase Complex-E1 Structure and Function.

Authors:  Hatice Gokcan; Jirair K Bedoyan; Olexandr Isayev
Journal:  J Chem Inf Model       Date:  2022-07-07       Impact factor: 6.162

7.  Solvent accessibility of E1α and E1β residues with known missense mutations causing pyruvate dehydrogenase complex (PDC) deficiency: Impact on PDC-E1 structure and function.

Authors:  Nicole H Ducich; Jason A Mears; Jirair K Bedoyan
Journal:  J Inherit Metab Dis       Date:  2022-02-01       Impact factor: 4.750

8.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency.

Authors:  Attila Ambrus; Junjie Wang; Reka Mizsei; Zsofia Zambo; Beata Torocsik; Frank Jordan; Vera Adam-Vizi
Journal:  Biochim Biophys Acta       Date:  2016-08-18

Review 9.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

10.  Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.

Authors:  Xiaoli Zhou; Shanshan Yu; Jing Su; Liankun Sun
Journal:  Int J Mol Sci       Date:  2016-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.